Josh Levitsky
Overview
Explore the profile of Josh Levitsky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
191
Citations
2510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Jesse M, Jackson W, Liapakis A, Ganesh S, Humar A, Goldaracena N, et al.
Clin Transplant
. 2023 Mar;
37(7):e14954.
PMID: 36892182
Introduction: Living donor liver transplantation (LDLT) is a promising option for mitigating the deceased donor organ shortage and reducing waitlist mortality. Despite excellent outcomes and data supporting expanding candidate indications...
22.
Sykes M, Chandran S, Kawai T, Levitsky J, Mapara M, Mathew J, et al.
Transplantation
. 2023 Feb;
107(3):564-569.
PMID: 36808845
No abstract available.
23.
Kim M, Sise M, Xu M, Goldberg D, Fontana R, Kort J, et al.
Clin Transplant
. 2023 Feb;
37(4):e14926.
PMID: 36752566
Our previous Multicenter Trial to Transplant HCV-infected Kidneys (MYTHIC) observed that 100% of hepatitis C virus (HCV)-uninfected patients who received a kidney from an HCV-infected deceased donor were cured of...
24.
Tang Q, Leung J, Peng Y, Sanchez-Fueyo A, Lozano J, Lam A, et al.
Sci Transl Med
. 2022 Nov;
14(669):eabo2628.
PMID: 36322627
Promoting immune tolerance to transplanted organs can minimize the amount of immunosuppressive drugs that patients need to take, reducing lifetime risks of mortality and morbidity. Regulatory T cells (T) are...
25.
Bhat M, Pasini E, Patel P, Yu J, Baciu C, Kurian S, et al.
Cancer Med
. 2022 Oct;
12(4):5150-5157.
PMID: 36205189
Long-term survival of transplant recipients is significantly impacted by malignancy. We aimed to determine whether calcineurin inhibitor (CNI)-treated recipients converted to and weaned off molecular target of rapamycin inhibitor (mTOR-I)...
26.
Thuluvath A, Siddiqui O, Lai J, Peipert J, Levitsky J, Daud A, et al.
Transplantation
. 2022 Sep;
107(2):420-428.
PMID: 36173424
Background: Personality traits influence clinical outcomes in chronic diseases, but their impact in cirrhosis is unknown. We studied the personality of patients with cirrhosis undergoing liver transplant (LT) evaluation and...
27.
Liu X, Taylor S, Celaj S, Levitsky J, Green R
BMC Gastroenterol
. 2022 Aug;
22(1):380.
PMID: 35948878
Background: Cholestatic liver diseases are a major source of morbidity and mortality that can progress to end-stage liver disease and hyperbilirubinemia is a hallmark of cholestasis. There are few effective...
28.
Harrington C, Levitsky J
Clin Liver Dis (Hoboken)
. 2022 Jul;
20(1):21-24.
PMID: 35899242
Content available: Audio Recording.
29.
Harrington C, Krishnan S, Mack C, Cravedi P, Assis D, Levitsky J
Hepatology
. 2022 May;
76(6):1862-1879.
PMID: 35611859
Autoimmune hepatitis (AIH) is a rare disease of unclear etiology characterized by loss of self-tolerance that can lead to liver injury, cirrhosis, and acute liver failure. First-line treatment consists of...
30.